Clinical Trial Update: A Clinical Study of SHR-4394 in Combination With Anti-tumor Therapy in Prostate Cancer [Phase 1, Phase 2]

View source ↗

Summary

This entry outlines a Phase 1/2 clinical study evaluating SHR-4394 in combination with anti-tumor therapy for prostate cancer, currently recruitment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• SHR-4394

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Prostate Cancer | Phase 1, Phase 2 | Status: RECRUITING